Loading stock analysis…
Evidence Synthesis
Last synthesized: 10 Jul 2026, 00:23
Narrative updating · score is newerEvidence Synthesis
MEDPLUS has accelerated its 26.23% gross margin from 5 % (quarterly cadence).
The marginal operating leverage also accelerated from 3.19 % (quarterly cadence). The company's revenue growth rate has been year-over-year.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 26.23 % | 5 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 5 % | 3.19 | ▲ |
| REVENUE_GROWTH_YOY | 23.5 % | 24.1 | ▼ |
| EPS_ACTUAL | 3.53 INR | 4.62 | ▼ |
| EPS_SURPRISE_PERCENT | 0.239 % | 0.113 | ▲ |
| PRICE_CHANGE_PERCENT | -1.26 % | — | - |
| DAILY_VOLUME | 24,218 shares | 2,05,604 | ▼ |
| CLOSE_PRICE | 806.35 INR | 816.65 | ▼ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 1 count | 6 | ▼ |
| TARGET_PRICE_PREMIUM | 44.94 % | — | - |